Alerts will be sent to your verified email
Verify Email
SAMRATPH
|
Samrat Pharmachem
|
Mercury Laboratories
|
Bharat Immunological
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.36 % | 10.51 % | -29.83 % |
|
5yr average Equity Multiplier
|
1.97 | 1.49 | 3.08 |
|
5yr Average Asset Turnover Ratio
|
2.61 | 1.05 | 0.61 |
|
5yr Avg Net Profit Margin
|
3.99 % | 6.6 % | -18.38 % |
|
Price to Book
|
1.36 | 1.87 | 1.21 |
|
P/E
|
20.39 | 26.48 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
59.17 Days | -4.69 Days | 206.63 Days |
|
Inventory Days
|
27.69 Days | 32.68 Days | 125.06 Days |
|
Days Receivable
|
78.39 Days | 115.65 Days | 61.4 Days |
|
Days Payable
|
45.36 Days | 157.73 Days | 117.81 Days |
|
5yr Average Interest Coverage Ratio
|
14.72 | 15.15 | -2.32 |
|
5yr Avg ROCE
|
30.03 % | 13.49 % | -44.64 % |
|
5yr Avg Operating Profit Margin
|
5.83 % | 11.74 % | -18.7 % |
|
5 yr average Debt to Equity
|
0.26 | 0.13 | 0.71 |
|
5yr CAGR Net Profit
|
-12.62 % | -10.08 % | 23.51 % |
|
5yr Average Return on Assets
|
10.58 % | 7.02 % | -10.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.09 % | 73.66 % | 59.25 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.56 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Samrat Pharmachem
|
Mercury Laboratories
|
Bharat Immunological
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|